Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks.
The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.” Read more
Share prices for Mazor Robotics slid today despite preliminary 1st-quarter sales numbers that beat expectations on Wall Street.
The Caesarea, Israel-based robot-assisted surgery device maker said it expects to post sales of $11.5 million for the 3 months ended March 31, ahead of The Street’s $11.2 million forecast and up 79.7% compared with Q1 2016. Investors reacted by sending MZOR shares down -1.6% to $29.11 apiece today in late-morning trading. Analysts are looking for Q1 losses per share of -21¢ and full-year losses of -81¢ on sales of $51.9 million. Read more
Medtronic issued a voluntary field corrective action today for all of the Newport HT70 and Newport HT70 Plus ventilators manufactured since 2010. The company said it received reports that the machine may reset spontaneously during normal operation, without an alarm.
After the device resets, it enters standby mode and will not resume ventilation, unless otherwise prompted by a trained healthcare professional. Read more
The European Parliament voted today to tighten its regulations on medical devices and diagnostics, enacting stronger post-market surveillance rules and adding a safety check for high-risk devices.
The new rules, which also mandate a unique identification system and implant cards for patients, are slated to go into effect 3 years after they’re officially published in early May for medical devices and 5 years for in vitro diagnostics. Read more
Intuitive Surgical stocks are up today on rumors that the company may be looking at a takeover from a larger player in medtech.
Shares have ticked up nearly 1%, up $7.11 at $769.45 today due to the rumors, according to Seeking Alpha. Read more